Evaluation of a sparse sampling strategy for determining vancomycin pharmacokinetics in preterm neonates: Application of optimal sampling theory

被引:11
作者
Burstein, AH
Gal, P
Forrest, A
机构
[1] MOSES CONE MEM HOSP,GREENSBORO AREA HLTH EDUC CTR,DIV PHARM,GREENSBORO,NC
[2] WOMENS HOSP GREENSBORO,GREENSBORO,NC
[3] UNIV N CAROLINA,DEPT PHARM PRACTICE,CHAPEL HILL,NC
[4] SUNY BUFFALO,DEPT PHARM PRACTICE,BUFFALO,NY 14260
[5] MILLARD FILLMORE HOSP,CLIN PHARMACOKINET LAB,BUFFALO,NY 14209
关键词
vancomycin; pharmacokinetics; neonates;
D O I
10.1177/106002809703100904
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To use optimal sampling theory to determine the fewest vancomycin concentrations required and the appropriate sampling times to calculate vancomycin pharmacokinetic parameters in neonates. DESIGN: Unblinded evaluation in neonates with presumed sepsis. SETTING: Level 3 community-based neonatal intensive care unit. PATIENTS: Eleven neonates with presumed sepsis. INTERVENTIONS: Twelve courses of intravenous vancomycin 20 mg/kg were administered. Blood samples were collected 3 and 9 hours after initiation of a 1-hour infusion of the first dose. MEASUREMENTS AND MAIN RESULTS: A two-compartment model was fit to vancomycin concentrations using iterative two-stage analysis. Pharmacokinetic parameter estimates were used for determination of optimal sampling times for two-, three-, and four-sample concentration data for 100 cases. Relative performance of strategies was compared through calculation and comparison of D efficiency for the determined strategies. Bias (median percent error) and precision (median percent absolute error) of pharmacokinetic parameter estimates for each strategy in the 100 simulated cases were determined. CONCLUSIONS: For estimation of total clearance and volume in the central and peripheral compartments, all strategies performed similarly with no difference in efficiency or bias and precision of estimates. Our results suggest that for clinical evaluations two appropriately timed samples (0.5 h after a 1-h infusion, trough concentration) are adequate for estimation for vancomycin clearance in neonates.
引用
收藏
页码:980 / 983
页数:4
相关论文
共 13 条
[1]  
ASBURY WH, 1993, ANN PHARMACOTHER, V27, P490
[2]   SIMPLIFIED SCORE FOR ASSESSMENT OF FETAL MATURATION OF NEWLY BORN INFANTS [J].
BALLARD, JL ;
NOVAK, KK ;
DRIVER, M .
JOURNAL OF PEDIATRICS, 1979, 95 (05) :769-774
[3]  
DARGENIO D, 1992, ADAPT 2 USERS GUIDE
[4]   OPTIMAL SAMPLING TIMES FOR PHARMACOKINETIC EXPERIMENTS [J].
DARGENIO, DZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :739-756
[5]  
FORREST A, 1991, CLIN PHARMACOL THER, V49, P153
[6]   COAGULASE-NEGATIVE STAPHYLOCOCCAL INFECTIONS IN NEONATES [J].
HALL, SL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (01) :57-67
[7]   VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS [J].
JAMES, A ;
KOREN, G ;
MILLIKEN, J ;
SOLDIN, S ;
PROBER, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :52-54
[8]  
LEONARD MB, 1989, PEDIATR INFECT DIS J, V8, P282
[9]   ETHICS OF DRUG STUDIES IN INFANTS - HOW MANY SAMPLES ARE REQUIRED FOR ACCURATE ESTIMATION OF PHARMACOKINETIC PARAMETERS IN NEONATES [J].
LONG, D ;
KOREN, G ;
JAMES, A .
JOURNAL OF PEDIATRICS, 1987, 111 (06) :918-921
[10]   VANCOMYCIN PHARMACOKINETICS IN SMALL, SERIOUSLY ILL INFANTS [J].
NAQVI, SH ;
KEENAN, WJ ;
REICHLEY, RM ;
FORTUNE, KP .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1986, 140 (02) :107-110